Design and Screening of Bispecific ADCs Discovered in RenLite Common Light Chain Antibody Mice_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Design,and,Screening,of,Bispecific,ADCs,Discovered,in,RenLite,Common,Light,Chain,Antibody,Mice

top

Please input keywords

ニュース&PR

お問い合わせ

JP

私たちの歩み

管理スタッフ

社会的責任

Antibody Assets

Project Integrum

Antibody discovery platforms

Clinical pipeline

Preclinical pipeline

動物・細胞モデル

Pharmacology service

ゲノム編集

Stock Information

Financial Reports

Listing Documents

Announcements & Notices

Corporate Governance

Investor Calendar

ウェビナー

Design and Screening of Bispecific ADCs Discovered in RenLite Common Light Chain Antibody Mice

2022.04.06

Prev:Antibody Screening Strategy us...

Next:Bispecific Antibody-Drug Conju...